This bias towards FGFR2-IIIb is particular to stomach tumors, as both isoforms present similar RNA expression levels in normal stomach, revealing a tight control of this process in normal tissue as opposed to cancer. This evidence concerns the gene FGFR2 and gastric neoplasm.